Search In this Thesis
   Search In this Thesis  
العنوان
Role of Amniotic Membrane in Healing of Skin Graft Donor Site /
المؤلف
Mostafa, Abd Algawad Mostafa Hakim.
هيئة الاعداد
باحث / عبدالجواد مصطفى حكيم مصطفى
مشرف / عبده محمد عبدالله درويش
مشرف / أحمد محمد عطية
الموضوع
Surgery.
تاريخ النشر
2021.
عدد الصفحات
73 p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
جراحة
تاريخ الإجازة
1/1/2021
مكان الإجازة
جامعة المنيا - كلية الطب - الجراحة العامة
الفهرس
Only 14 pages are availabe for public view

from 78

from 78

Abstract

Split-thickness skin graft donor site dressing still remains under debate.
Materials and methods for wound dressing should provide adequate coverage to the donor site so that the wound rapidly reepithelializes spontaneously and to prevent the development of complications while giving the patient a state of physical and mental well-being during the healing process.
Amniotic membrane is one of the most widely used temporary biological dressing . Ease of availability, negligible cost and facilitated wound healing makes this temporary biological dressing generally superior to conventional dressing . The epithelium in human amniotic membrane provides good protection from evaporative loss, as well as barrier function, whereas the fibronectin and collagen matrix provide some dermal function.
Our study was carried on 20 patients scheduled for split thickness skin graft,with post burn or post traumatic rowa area ,subjected for application of amniotic membrane on the half area of donor site This study showed that the use of amniotic membrane as adressing for split thickness graft donor site accelerate healing and reduce healing time ,when compared to conventional dressing .
Time of healing of the studied group show that time of healing for conventional dressing was ranged between 7 – 16 days with a mean value of 12.10±1.714 days while time of healing for amniotic membrane dressing ranged between 7 – 14 days with a mean value of 10.75±2.023 days. There were statistically significant differences between the two types of treatment where P=0.035.